Medical Writing Observational Studies Guidelines for disclosing the results from observational trials

Volume 26, Issue 3 - Observational Studies

Guidelines for disclosing the results from observational trials


Observational trials are a relevant part of clinical research. Publishing their results can be challenging for scientists and writers.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement was the first guideline developed to identify the minimal information that should be included in articles reporting observational and epidemiological research. More than 50 ancillary guidelines tailored to specific needs are now available to assist authors in preparing successful articles on observational studies.
Download the full article


  1. Altman DG. Practical statistics for medical research. London, UK: Chapman & Hall; 1991. Available from: http://
  2. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996;312:1215–8. Available from: http://
  3. Lauer MS, D’Agostino RB, Sr. The randomized registry trial – the next disruptive technology in clinical research? N Engl J Med 2013;369:1579–81. Available from: http://
  4. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. Strength - ening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806–8. Available from: http://
  5. Pocock SJ, Collier TJ, Dandreo KJ, de Stavola BL, Goldman MB, Kalish LA et al. Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ 2004;329:883. Available from: http://
  6. Lee W, Bindman J, Ford T, Glozier N, Moran P, Stewart R, Hotopf M. Bias in psychiatric case-control studies: literature survey. Br J Psychiatry 2007;190:204–9. Available from: http://
  7. Tooth L, Ware R, Bain C, Purdie DM, Dobson A. Quality of reporting of observational longitudinal research. Am J Epidemiol 2005;161:280–8. Available from: http://
  8. Vandenbroucke JP, von Elm E, Altman DG et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 2007;18:805–35. Available from: http://
  9. Golub RM, Fontanarosa PB. Researchers, readers, and reporting guidelines: writing between the lines. JAMA 2015; 313:1625-6. Available from: http://
  10. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel–group randomised trials. Lancet 2001;357:{1191–4. Available from: http://
  11. University of Bern. Translations of STROBE Statement. 2009 [cited 2017 Jun 2]. Available from: Available from:
  12. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: consensus–based clinical case report guide - line development. J Clin Epidemiol 2014;67:46–51. Available from: http://
  13. Little J, Higgins JP, Ioannidis JP et al. STrengthening the REporting of Genetic Association studies (STREGA) – an extension of the STROBE statement. Eur J Clin Invest 2009;39:247–66. Available from: http://
  14. Benchimol EI, Smeeth L, Guttmann A et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med 2015;12:e1001885. Available from: http://
  15. Agha RA, Fowler AJ, Rajmohan S, Barai I, Orgill DP. Preferred reporting of case series in surgery; the PROCESS guidelines. Int J Surg 2016;36:319–23. Available from: http://
  16. Rodgers M, Thomas S, Harden M, Parker G, Street A, Eastwood A. Developing a methodological framework for organisational case studies: a rapid review and consensus dev el - opment process. Southampton (UK), 2016. Available from: http://
  17. Coroneos CJ, Ignacy TA, Thoma A. Designing and reporting case series in plastic surgery. Plast Reconstr Surg 2011;128:361e–8e. Available from: http://
  18. Rubino M, Pragnell MVC. Guidelines for reporting case series of tumours of the colon and rectum. Tech Coloproct 1999;3:93–7. Available from: http://
  19. Kempen JH. Appropriate use and reporting of uncontrolled case series in the medical literature. Am J Ophthalmol 2011;151: 7–10 e1. Available from: http://
  20. White A. Conducting and reporting case series and audits – author guidelines for acupuncture in medicine. Acupunct Med 2005;23:181–7. Available from: http://
  21. Lavergne V, Ouellet G, Bouchard J et al. Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology. Semin Dial 2014;27:407–14. Available from: http://
  22. Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E–Surveys (CHERRIES). J Med Internet Res 2004;6:e34. Available from: http://
  23. Burns KE, Duffett M, Kho ME, Meade MO, Adhikari NK, Sinuff T, Cook DJ. A guide for the design and conduct of self– administered surveys of clinicians. CMAJ 2008;179:245–52. Available from: http://
  24. Agarwal S, LeFevre AE, Lee J et al. Guidelines for reporting of health interventions using mobile phones: mobile health (mHealth) evidence reporting and assessment (mERA) checklist. BMJ 2016;352:i1174 Available from: http://
  25. Kelley K, Clark B, Brown V, Sitzia J. Good practice in the conduct and reporting of survey research. Int J Qual Health Care 2003;15:261–6. Available from: http://
  26. Gallo V, Egger M, McCormack V et al. STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement. PLoS Med 2011;8:e1001117. Available from: http://
  27. Hollenbach JA, Mack SJ, Gourraud PA et al. A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. Tissue Antigens 2011;78:333–44. Available from: http://
  28. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Clin Invest 2011;41:1004–9. Available from: http://
  29. Bruck K, Jager KJ, Dounousi E et al. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrol Dial Transplant 2016;31:680. Available from: http://
  30. Bennett DA, Brayne C, Feigin VL et al. Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology. Eur J Epidemiol 2015;30:569–76. Available from: http://
  31. Lachat C, Hawwash D, Ocke MC et al. Strengthening the Reporting of Observational Studies in Epidemiology– Nutritional Epidemiology (STROBE–nut): An Extension of the STROBE Statement. PLoS Med 2016;13:e1002036. Available from: http://
  32. Stevens GA, Alkema L, Black RE et al. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet 2016;388:e19–e23. Available from: http://
  33. Fitchett EJ, Seale AC, Vergnano S et al. Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Lancet Infect Dis 2016;16:e202–13. Available from: http://
  34. Tacconelli E, Cataldo MA, Paul M et al. STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship. BMJ Open 2016;6:e010134. Available from: http://
  35. Field N, Cohen T, Struelens MJ et al. Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement. Lancet Infect Dis 2014;14:341–52. Available from: http://
  36. Stone SP, Cooper BS, Kibbler CC et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother 2007;59:833–40. 28 | September 2017 Medical Writing | Volume 26 Number 3 Guidelines for disclosing the results from observational trials – Rossi et al Available from: http://
  37. Horby PW, Laurie KL, Cowling BJ et al. CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement. Influenza Other Respir Viruses 2017;11:2–14. Available from: http://
  38. Zavada J, Dixon WG, Askling J. Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries. Ann Rheum Dis 2014;73:628. Available from: http://
  39. Dixon WG, Carmona L, Finckh A et al. EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. Ann Rheum Dis 2010;69:1596–602. Available from: http://
  40. Moore CM, Giganti F, Albertsen P et al. Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations- A Report of a European School of Oncology Task Force. Eur Urol 2017;71:648–55. Available from: http://
  41. Moore CM, Kasivisvanathan V, Eggener S et al. Standards of reporting for MRI–targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol 2013;64:544–52. Available from: http://
  42. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 2005;93:387–91. Available from: http://
  43. Hlatky MA, Greenland P, Arnett DK et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009;119:2408–16. Available from: http://
  44. Quintana DS, Alvares GA, Heathers JA. Guidelines for Reporting Articles on Psychiatry and Heart rate variability (GRAPH): recommendations to advance research communication. Transl Psychiatry 2016;6:e803. Available from: http://
  45. Wardlaw JM, Smith EE, Biessels GJ et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822–38. Available from: http://
  46. Creinin MD, Chen MJ. Medical abortion reporting of efficacy: the MARE guidelines. Contraception 2016;94:97–103. Available from: http://
  47. Rosenthal R, Hoffmann H, Clavien PA, Bucher HC, Dell-Kuster S. Definition and Classification of Intraoperative Complications (CLASSIC): Delphi Study and Pilot Evaluation. World J Surg 2015;39:1663–71. Available from: http://
  48. Bordeianu CD, Ticu CE. A new manner of reporting pressure results after glaucoma surgery. Clin Ophthalmol 2012;6:23–31. Available from: http://
  49. Brethauer SA, Kim J, el Chaar M et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis 2015;11:489–506. Available from: http://
  50. Sun BC, Thiruganasambandamoorthy V, Cruz JD. Standardized reporting guidelines for emergency department syncope riskstratification research. Acad Emerg Med 2012;19:694–702. Available from: http://
  51. Bradt DA, Aitken P. Disaster medicine reporting: the need for new guidelines and the CONFIDE statement. Emerg Med Australas 2010;22:483–7. Available from: http://
  52. Smith SM, Hunsinger M, McKeown A et al. Quality of pain intensity assessment reporting: ACTTION systematic review and recommendations. J Pain 2015; 16:299– 305. Available from: http://
  53. Dionne CE, Dunn KM, Croft PR et al. A consensus approach toward the standardization of back pain definitions for use in prevalence studies. Spine (Phila Pa 1976) 2008;33:95–103. Available from: http://
  54. Jason LA, Unger ER, Dimitrakoff JD et al. Minimum data elements for research reports on CFS. Brain Behav Immun 2012;26:401–6. Available from: http://
  55. Leech NL, Onwuegbuzie AJ. Guidelines for conducting and reporting mixed research in the field of counseling and beyond. J Couns Dev 2010;88:61–9. Available from: http://
  56. Crawford JR, Garthwaite PH, Porter S. Point and interval estimates of effect sizes for the case-controls design in neuropsychology: rationale, methods, implementations, and proposed reporting standards. Cogn Neuropsychol 2010;27:245–60. Available from: http://
  57. Singh JP, Yang S, Mulvey EP. Reporting guidance for violence risk assessment predictive validity studies: the RAGEE Statement. Law Hum Behav 2015;39:15–22. Available from: http://
  58. Kearon C, Iorio A, Palareti G. Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting. J Thromb Haemost 2010;8:2313–5. Available from: http://
  59. Meyers PM, Schumacher HC, Higashida RT et al. Reporting standards for endovascular repair of saccular intracranial cerebral aneurysms. J Neurointerv Surg 2010;2: 312–23. Available from: http://
  60. Wu T, Shang H, Bian Z, Zhang J, Li T, Li Y, Zhang B. Recommendations for reporting adverse drug reactions and adverse events of traditional Chinese medicine. J Evid Based Med 2010;3:11–7. Available from: http://
  61. Melby MK, Sievert LL, Anderson D, Obermeyer CM. Overview of methods used in cross-cultural comparisons of menopausal symptoms and their determinants: Guidelines for Strengthening the Reporting of Menopause and Aging (STROMA) studies. Maturitas 2011;70:99–109. Available from: http://
  62. Higginson IJ, Evans CJ, Grande G et al. Evaluating complex interventions in end of life care: the MORECare statement on good practice generated by a synthesis of transparent expert consultations and systematic reviews. BMC Med 2013;11:111. Available from: http://
  63. Gershman MD, Staples JE, Bentsi-Enchill AD et al. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunisation safety data. Vaccine 2012;30:5038–58. Available from: http://
  64. Sargeant JM, O’Connor AM, Dohoo IR et al. Methods and processes of developing the strengthening the reporting of observational studies in epidemiology – veterinary (STROBE-Vet) statement. Prev Vet Med 2016;134:188–96. Available from: http://
  65. Cheng A, Kessler D, Mackinnon R et al. Reporting Guidelines for Health Care Simulation Research: Extensions to the CONSORT and STROBE Statements. Simul Healthc 2016;11:238–48. Available from: http://
  66. White RG, Hakim AJ, Salganik MJ et al. Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: “STROBE-RDS” statement. J Clin Epidemiol 2015;68:1463–71. Available from: http://
  67. Schriger DL. Suggestions for improving the reporting of clinical research: the role of narrative. Ann Emerg Med 2005;45:437–43. Available from: http://
  68. Hrynaszkiewicz I, Norton ML, Vickers AJ, Altman DG. Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers. BMJ 2010;340:c181. Available from: http://
  69. Olson SH, Voigt LF, Begg CB, Weiss NS. Reporting participation in case–control studies. Epidemiology 2002;13:123–6. Available from: http://
  70. Brookhart MA, Rassen JA, Schneeweiss S. Instrumental variable methods in comparative safety and effectiveness research. Pharmacoepidemiol Drug Saf 2010;19:537–54. Available from: http://



Observations and Observational Studies
President's Message
RCTs: Can the treatment work? Patient registries: Does the treatment work?
Odd cases and risky cohorts: Measures of risk and association in observational studies
Guidance for the design and analysis of observational studies: The STRengthening Analytical Thinking for Observational Studies (STRATOS) initiative
Guidelines for disclosing the results from observational trials
Registration and ethics committee approval for observational studies: Current status and way forward
Regulatory submissions of non-interventional post-authorisation safety studies
Reporting non-interventional post-authorisation safety studies (NI-PASS)
Patient-reported outcomes: How useful are they?
EMA releases the revised Good Pharmacovigilance Practices Module V – updated guidance on risk management plans
Mentoring tomorrow’s medical writers
ICMJE to mandate data sharing statements
News from the EMA
Journal Watch
Getting Your Foot in the Door
In the Bookstores
Regulatory Matters
Medical Communications
The Webscout
Teaching Medical Writing
Good Writing Practice
Out on Our Own


The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Editoral Board


Raquel Billiones


Evguenia Alechine

Jonathan Pitt

Managing Editor

Victoria White

Deputy Managing Editor

Alicia Brooks Waltman

Associate Editors

Anuradha Alahari

Jennifer Bell

Nicole Bezuidenhout

Claire Chang

Barbara Grossman

Sarah Milner

John Plant

Sampoorna Rappaz

Amy Whereat

Section Editors

Daniela Kamir


Jennifer Bell


Nicole Bezuidenhout 

Digital Communication

Somsuvro Basu

EMWA News 

Ana Sofia Correia 

Gained in Translation

Ivana Turek

Getting Your Foot in the Door

Wendy Kingdom / Amy Whereat

Good Writing Practice

Alison McIntosh 

In the Bookstores

Maria Kołtowska-Häggström

Lingua Franca and Beyond

Maddy Dyer


Lisa Chamberlain-James

Medical Communications/Writing for Patients

Payal Bhatia

Medical Devices

Evguenia Alechine

My First Medical Writing

Anuradha Alahari

News from the EMA

Adriana Rocha


Tiziana von Bruchhausen


Clare ChangZuo Yen Lee 

Regulatory Matters

Sam Hamilton

Regulatory Public Disclosure

Claire Gudex

Teaching Medical Writing

Louisa Ludwig-Begall / Sarah Kabani

The Crofter: Sustainable Communications

Louisa Marcombes

Veterinary Writing

Editors Emeritus

Elise Langdon-Neuner

Phil Leventhal

Layout Designer

Chris Monk